77,917 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 77,917 shares of the company's stock, valued at approximately $1,391,000. Russell Investments Group Ltd. owned approximately 0.23% of Grail at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Envestnet Asset Management Inc. bought a new position in Grail in the 4th quarter worth approximately $337,000. Wells Fargo & Company MN acquired a new position in Grail in the fourth quarter valued at approximately $90,000. Geode Capital Management LLC bought a new position in Grail in the fourth quarter valued at approximately $7,920,000. Alliancebernstein L.P. acquired a new stake in Grail during the 4th quarter worth $250,000. Finally, Wellington Management Group LLP bought a new stake in shares of Grail during the 4th quarter valued at $408,000.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on GRAL shares. Canaccord Genuity Group assumed coverage on Grail in a research report on Monday. They issued a "buy" rating and a $32.00 price target on the stock. Morgan Stanley boosted their target price on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Trading Down 2.9 %

Shares of NASDAQ GRAL traded down $1.10 during midday trading on Friday, reaching $36.60. 353,756 shares of the stock were exchanged, compared to its average volume of 1,220,546. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99. The business has a 50-day simple moving average of $31.34 and a two-hundred day simple moving average of $24.09.

Grail (NASDAQ:GRAL - Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The business had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. Equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Insider Activity

In other Grail news, President Joshua J. Ofman sold 2,109 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the sale, the president now directly owns 559,673 shares in the company, valued at approximately $17,461,797.60. This trade represents a 0.38 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Aaron Freidin sold 1,816 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the transaction, the chief financial officer now directly owns 335,170 shares in the company, valued at approximately $10,457,304. The trade was a 0.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,550 shares of company stock worth $360,436 in the last 90 days.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.